Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes

Redox Biology

Volumn 4, Issue , 2015, Pages 34-39

  Broedbaek, Kasper ^a,b   Siersma, Volkert ^c   Henriksen, Trine ^a,b   Weimann, Allan ^a,b   Petersen, Morten ^a,b   Andersen, Jon T ^a,b   Jimenez Solem, Espen ^a,b   Hansen, Lars J ^c   Henriksen, Jan Erik ^d   Bonnema, Steen J ^d   de Fine Olivarius, Niels ^c   Friis, Søren ^e   Poulsen, Henrik E ^a,b,f  

^a Rigshospitalet   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

8 oxo 7,8 dihydro 2' deoxyguanosine; 8 oxo 7,8 dihydroguanosine; Cancer; DNA oxidation; RNA oxidation; Type 2 diabetes

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 OXO 7,8 DIHYDROGUANOSINE; BIOLOGICAL MARKER; GUANOSINE DERIVATIVE; NUCLEIC ACID; UNCLASSIFIED DRUG; 8-HYDROXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; DNA; GUANOSINE; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID OXIDATION; OXIDATION; RNA METABOLISM; URINALYSIS; URINARY EXCRETION; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; URINE;

AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DNA; DNA DAMAGE; FEMALE; GUANOSINE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; RNA;

EID: 84917690923     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.11.010     Document Type: Article

References (24)

1. Giovannucci E., Harlan D.M., Archer M.C., et al. Diabetes and cancer: a consensus report. Diabetes Care 2010, 33(7):1674-1685. http://www.ncbi.nlm.nih.gov/pubmed/20587728, 10.2337/dc10-0666.
2. Coughlin S.S., Calle E.E., Teras L.R., Petrelli J., Thun M.J. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American Journal of Epidemiology 2004, 159(12):1160-1167. http://www.ncbi.nlm.nih.gov/pubmed/15191933, 10.1093/aje/kwh161.
3. Vigneri P., Frasca F., Sciacca L., Pandini G., Vigneri R. Diabetes and cancer. Endocrine Related Cancer 2009, 16(4):1103-1123. http://www.ncbi.nlm.nih.gov/pubmed/19620249, 10.1677/ERC-09-0087.
4. Hemminki K., Li X., Sundquist J., Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010, 15(6):548-555. http://www.ncbi.nlm.nih.gov/pubmed/20479278, 10.1634/theoncologist.2009-0300.
5. Broedbaek K., Weimann A., Stovgaard E.S., Poulsen H.E. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes. Free Radical Biology and Medicine 2011, 51(8):1473-1479. http://www.ncbi.nlm.nih.gov/pubmed/21820047, 10.1016/j.freeradbiomed.2011.07.007.
6. Yamamoto T., Hosokawa K., Tamura T., Kanno H., Urabe M., Honjo H. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in women with or without gynecologic cancer. Journal of Obstetrics and Gynaecology Research 1996, 22(4):359-363. http://www.ncbi.nlm.nih.gov/pubmed/8870419.
7. Dziaman T., Huzarski T., Gackowski D., et al. Elevated level of 8-oxo-7,8-dihydro-2'-deoxyguanosine in leukocytes of BRCA1 mutation carriers compared to healthy controls. International Journal of Cancer 2009, 125(9):2209-2213. http://www.ncbi.nlm.nih.gov/pubmed/19623658, 10.1002/ijc.24600.
8. Kuo H.W., Chou S.Y., Hu T.W., Wu F.Y., Chen D.J. Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients. Mutation Research 2007, 631(1):62-68. http://www.ncbi.nlm.nih.gov/pubmed/17512776, 10.1016/j.mrgentox.2007.04.009.
9. Erhola M., Toyokuni S., Okada K., et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Letters 1997, 409(2):287-291. http://www.ncbi.nlm.nih.gov/pubmed/9202163, 10.1016/S0014-5793(97)00523-1.
10. Thanan R., Murata M., Pinlaor S., et al. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiology, Biomarkers & Prevention 2008, 17(3):518-524. http://www.ncbi.nlm.nih.gov/pubmed/18349269, 10.1158/1055-9965.EPI-07-2717.
11. Miyake H., Hara I., Kamidono S., Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. Journal of Urology 2004, 171(4):1533-1536. http://www.ncbi.nlm.nih.gov/pubmed/15017214, 10.1097/01.ju.0000116617.32728.ca.
12. Tagesson C., Källberg M., Klintenberg C., Starkhammar H. Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. European Journal of Cancer 1995, 31A(6):934-940. http://www.ncbi.nlm.nih.gov/pubmed/7646926, 10.1016/0959-8049(94)00490-0.
13. Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutation Research 2004, 567(1):1-61. http://www.ncbi.nlm.nih.gov/pubmed/15341901, 10.1016/j.mrrev.2003.11.001.
14. Broedbaek K., Siersma V., Henriksen T., et al. Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study. Diabetes Care 2013, 36(3):669-676. http://www.ncbi.nlm.nih.gov/pubmed/23150279, 10.2337/dc12-0998.
15. Broedbaek K., Siersma V., Henriksen T., et al. Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care 2011, 34(12):2594-2596. http://www.ncbi.nlm.nih.gov/pubmed/21994431, 10.2337/dc11-1620.
16. Olivarius N.F., Beck-Nielsen H., Andreasen A.H., Hørder M., Pedersen P.A. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. British Medical Journal 2001, 323(7319):970-975. http://www.ncbi.nlm.nih.gov/pubmed/11679387, 10.1136/bmj.323.7319.970.
17. Henriksen T., Hillestrøm P.R., Poulsen H.E., Weimann A. Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2'-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry. Free Radical Biology and Medicine 2009, 47(5):629-635. http://www.ncbi.nlm.nih.gov/pubmed/19501155, 10.1016/j.freeradbiomed.2009.06.002.
18. Gjerstorff M.L. The Danish cancer registry. Scandinavian Journal of Public Health 2011, 39(7 Suppl.):42-45. http://www.ncbi.nlm.nih.gov/pubmed/21775350, 10.1177/1403494810393562.
19. Loft S., Svoboda P., Kasai H., et al. Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis 2006, 27(6):1245-1250. http://www.ncbi.nlm.nih.gov/pubmed/16364924, 10.1093/carcin/bgi313.
20. Loft S., Olsen A., Møller P., Poulsen H.E., Tjønneland A. Association between 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and risk of postmenopausal breast cancer: nested case-control study. Cancer Epidemiology, Biomarkers & Prevention 2013, 22(7):1289-1296. http://www.ncbi.nlm.nih.gov/pubmed/23658396, 10.1158/1055-9965.EPI-13-0229.
21. David S.S., O'Shea V.L., Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007, 447(7147):941-950. http://www.ncbi.nlm.nih.gov/pubmed/17581577, 10.1038/nature05978.
22. Melis J.P., van Steeg H., Luijten M. Oxidative DNA damage and nucleotide excision repair. Antioxidants and Redox Signaling 2013, 18(18):2409-2419. http://www.ncbi.nlm.nih.gov/pubmed/23216312, 10.1089/ars.2012.5036.
23. Dizdaroglu M., Kirkali G., Jaruga P. Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects. Free Radical Biology and Medicine 2008, 45(12):1610-1621. http://www.ncbi.nlm.nih.gov/pubmed/18692130, 10.1016/j.freeradbiomed.2008.07.004.
24. Nohmi T., Kim S.R., Yamada M. Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutation Research 2005, 591(1-2):60-73. http://www.ncbi.nlm.nih.gov/pubmed/16081110, 10.1016/j.mrfmmm.2005.03.033.